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Compromised heat shock protein 90 (Hsp90) function reveals cryptic phenotypes in flies and plants. These
observations were interpreted to suggest that this molecular stress-response chaperone has a capacity to buffer
underlying genetic variation. Conversely, the protective role of Hsp90 could account for the variable penetrance or
severity of some heritable developmental malformations in vertebrates. Using zebrafish as a model, we defined Hsp90
inhibitor levels that did not induce a heat shock response or perturb phenotype in wild-type strains. Under these
conditions the severity of the recessive eye phenotype in sunrise, caused by a pax6b mutation, was increased, while in
dreumes, caused by a sufu mutation, it was decreased. In another strain, a previously unobserved spectrum of severe
structural eye malformations, reminiscent of anophthalmia, microphthalmia, and nanophthalmia complex in humans,
was uncovered by this limited inhibition of Hsp90 function. Inbreeding of offspring from selected unaffected carrier
parents led to significantly elevated malformation frequencies and revealed the oligogenic nature of this phenotype.
Unlike in Drosophila, Hsp90 inhibition can decrease developmental stability in zebrafish, as indicated by increased
asymmetric presentation of anophthalmia, microphthalmia, and nanophthalmia and sunrise phenotypes. Analysis of
the sunrise pax6b mutation suggests a molecular mechanism for the buffering of mutations by Hsp90. The zebrafish
studies imply that mild perturbation of Hsp90 function at critical developmental stages may underpin the variable
penetrance and expressivity of many developmental anomalies where the interaction between genotype and
environment plays a major role.
Citation: Yeyati PL, Bancewicz RM, Maule J, van Heyningen V (2007) Hsp90 selectively modulates phenotype in vertebrate development. PLoS Genet 3(3): e43. doi:10.1371/
journal.pgen.0030043
Introduction
Human malformations frequently show no clear Mendelian
inheritance pattern, even when familial recurrence suggests a
strong underlying genetic component. Such phenotypic
variability is generally deﬁned as incomplete penetrance or
variable expressivity [1,2], and it may be inﬂuenced by genetic
background as well as by environmental factors. Predicting
phenotypic outcomes for such cases is often an impossible
challenge in clinical genetics. As a corollary, it has become
clear that robustness of the wild-type (WT) phenotype to
extensive genetic and environmental variation may be
ascribed to the complexity, and hence strong buffering
capacity of gene networks and cellular surveillance mecha-
nisms [3,4]. These homeostatic systems are of major clinical
relevance as potential prophylactic and therapeutic targets.
Understanding the molecular events that can alter the
balance between cryptic and overt phenotypes is therefore
an important endeavour.
Based on observations in Drosophila [5], we set out to assess
the role of stress-response pathways, particularly of heat
shock protein 90 (Hsp90) function, in phenotype modiﬁca-
tion, using zebraﬁsh as a vertebrate model. Hsp90 proteins
are environmentally responsive chaperones, encoded at
multiple loci in vertebrates. Under normal conditions they
assist the maturation and folding of newly synthesised
proteins and escort metastable regulatory molecules such as
kinases and steroid hormone receptors [6]. In response to
mutation or environmental stress, additional Hsp90 capacity
is required to maintain newly destabilized proteins in a
folding competent state. An unexpected consequence of this
dual role is that Hsp90 can become functionally limiting, so
that overt phenotypes may be uncovered from previously
cryptic genetic variants, in spite of Hsp90 being further
induced under stress [7]. Two recent studies showed that
Hsp90 perturbation affects nearly all body parts in Drosophila
and numerous morphological phenotypes in Arabidopsis [5,8].
Most changes were recurrent in a strain-speciﬁc manner and
enriched by subsequent inbreeding, suggesting that they
arose from previously silent but preexisting genetic variants
[5]. Recently, it was proposed that Hsp90 can affect the
epigenetic state at speciﬁc loci, leading to phenotype
modulation [9]. Interfering with Hsp90 buffering therefore
has phenotypic consequences, which are dependent on
underlying genetic and epigenetic components, although it
is not clear whether some preexisting genetic change is
required for epigenetic inheritance of the trait [7].
The Hsp90 loci identiﬁed in humans have distinct
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HSP90AA1 and HSP90AB1, are expressed in the cytoplasm;
while GRP94, a glucose responsive form encoded by HSP90B1
resides in the endoplasmic reticulum; and there is a
mitochondrial form, TRAP1 (TNF receptor-associated pro-
tein 1). Genetic studies in mice suggest that despite the close
similarity between Hsp90aa1 and Hsp90ab1, these paralogues
are not functionally redundant [10]. The cytosolic Hsp90
proteins are thought to work as homodimers, but in
association with several cochaperones [11]. The homodimer
binds and releases its ‘‘client’’ proteins, aided by cochaper-
ones, in an ATP-driven cycle [12–14]. Hsp90 function from all
four loci is speciﬁcally inhibited by compounds like geldana-
mycin or radicicol, which compete with ATP for the
nucleotide-binding pocket, so disrupting Hsp90 activity
[15,16]. Inhibition shifts the cells from protein folding or
activation, to degradation of most, but not all, unfolded client
proteins by the proteasome system [17–20]. Complete loss of
Hsp90 function is lethal, as multiple essential pathways are
inactivated, a feature exploited in cancer treatment, where
tumour-cell growth is heavily dependent on mutated onco-
genic proteins that require Hsp90 assistance to function
during malignant progression (reviewed in [21] and [22]).
Increased binding afﬁnity of Hsp90 inhibitors to these
mutated protein complexes preferentially sensitises them to
Hsp90 inhibition, allowing differential killing of malignant
versus normal cells [23]. Use of Hsp90 inhibitors has also been
proposed for amelioration of protein-aggregation-associated
neurodegenerative diseases [24,25]. Hsp90 protein function is
required at all times in eukaryotic cells [26,27], but under
stress conditions higher levels are achieved through induc-
tion of a heat shock response. Recent genome-wide ap-
proaches have expanded the set of Hsp90 client proteins and
required cofactors that are thought to confer substrate
speciﬁcity [28–30]. These new ﬁndings are extending the role
of Hsp90 from protein folding to gene regulation (reviewed
in [31]) with potential impact on cellular epigenetic states
(reviewed in [32]). Hsp90 inhibitors used above a threshold
level induce a heat shock response through the activation of
heat shock factor 1, which is normally silenced by association
with Hsp90 [33].
Classical examples of developmental anomalies with
variable severity and penetrance include holoprosencephaly,
neural tube defects, cleft lip and palate, and heart malforma-
tions. Recently our human disease interests have focused on
severe eye malformations, such as anophthalmia, micro-
phthalmia, and coloboma [34–36]. These provide additional
good examples of non-Mendelian inheritance patterns, where
the relative contribution of environmental and genetic
factors to the complex phenotypes remains controversial. If
vertebrate phenotypes are also modulated by Hsp90, these
could provide the molecular link between periodic environ-
mental ﬂuctuation and the overt manifestation of genetic
susceptibility. If the chaperone system plays a buffering role
in the variability of certain mutant phenotypes, compromis-
ing Hsp90 function may alter the severity or penetrance of
some deﬁned traits without affecting overall development.
Here we report that previously unobserved speciﬁc devel-
opmental anomalies were uncovered following partial inhib-
ition of Hsp90 function in zebraﬁsh. The spectrum of
phenotypes observed and the organ systems affected depend
both on the strain used and on the developmental stage at
which the carefully controlled Hsp90 inhibitor is adminis-
tered. Breeding studies clearly indicate that the phenotypes
are manifestations of underlying cryptic genetic variation.
Under our conditions, WT strains do not give rise to the rare
malformations we observed in some mutant strains but do
reveal more common anomalies that may reﬂect the
uncovering of generally silent common gene variants. In
addition to the de novo exposure of cryptic variation, we also
showed that Hsp90 inhibition can modify the severity of
some, but not all, already characterized developmental
anomalies. Phenotype amelioration was observed in one case
and increased severity in another. Both of the modiﬁed
phenotypes were characterized as missense mutations at
different loci. No phenotype modulation was observed at two
different loci where the mutations had been identiﬁed as
nonsense changes. Molecular studies show that in the
presence of Hsp90 inhibition one of the mutant proteins
studied is rapidly decreased, while its WT allele is largely
unaffected, providing a molecular model for Hsp90 modu-
lation of phenotype at the organismal level.
Results
Establishing Drug, Morpholino Doses, and Treatment
Timing in WT Strains
Geldanamycin (GA) has been used previously to examine
the requirement for Hsp90 during zebraﬁsh development
[37]. The drug dose used (35 lM GA) led to developmental
malformations in 80% of the treated embryos regardless of
the strains tested [37], and therefore independently of
underlying genetic background.
To investigate treatment conditions that could affect the
phenotypic outcome selectively in a strain-speciﬁc manner,
we initially assessed the developmental stages and highest
drug doses at which Hsp90 function is decreased without
affecting viability, or inducing highly penetrant or severe
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Author Summary
Genetic variation is not always expressed as a single consistent
phenotype even in familial diseases. Unilateral malformations in
paired organs, such as the failure of an eye to develop on one side
only, also remind us that gene function is often modified by
environmental factors. Following observations by others in fruit flies,
we explored the underlying mechanisms for such phenotypic
fluctuation, using zebrafish as a vertebrate model. Earlier work
suggested involvement of chaperone proteins like Hsp90, which
assist with normal protein folding during development and also
work overtime to keep proteins functional in response to environ-
mental stress. Using specific drugs at defined times in early
development for the limited reduction of Hsp90 activity, we showed
that different cryptic genetic variants could be revealed consistently
in genetically distinct fish strains. Once uncovered, the frequency of
these variants was increased by inbreeding, confirming the role of
underlying genetic factors. Similarly, we could modify the pheno-
typic severity of some—but not all—known gene variants, worsen-
ing some and improving others. It emerged that the most
susceptible variants were those carrying amino acid alterations, in
which assisted protein folding may either restore near normal
function or facilitate malfunction, thus worsening phenotype. This
insight may allow us to prevent recurrent malformations by
minimizing or perhaps even counteracting the effects of exposure
to environmental stress during development.developmental defects in WT strains (Table 1). Hsp90
function was reduced by treating embryos with radicicol (a
macrolactone), which is functionally equivalent to but
structurally distinct from GA (a benzoquinone ansanamycin).
Subsequently we also used the GA class inhibitor 17-
allylamino-17-demethoxygeldanamycin (17AAG) [38], which
has low toxicity and is now in clinical trials for cancer therapy
[21]. Morpholinos, for knocking down the activity of the two
cytoplasmic forms of Hsp90 alpha (hsp90a [Danio rerio] and
HSP90AA1 [Homo sapiens]) and Hsp90 beta (hsp90ab1 [D. rerio]
and HSP90AB1 [H. sapiens]), were also used as additional
controls for drug-speciﬁc inhibition of Hsp90.
We tested a range of doses at 30% and 50% epiboly and
recorded novel phenotypes and viability. When treatment was
initiated at 30% epiboly (deﬁned as 4.6 h postfertilization
[hpf]), both drugs caused multiple phenotypes and reduced
viability assessed at 24–48 hpf. For example, among those
surviving to 24 hpf following treatment with 10 lM radicicol
or 3.3 lM 17AAG, we repeatedly observed growth retarda-
tion, decreased pigmentation, pericardial oedema with or
without abnormal heart morphology, ﬁn-fold, and notochord
defects (Figure 1B–1K). Both drugs caused mild oedema and
rarely severe oedema with altered heart morphology (Figure
1I and 1J; Video S1). 17AAG also elicited inversion of left-
right heart looping or heterotaxia in very high frequencies
(Figure 1M; Videos S2 and S3), while after radicicol treatment
only a few embryos displayed abnormal heart looping in the
absence of oedema (Figure 1N, Videos S4–S6). Radicicol also
produced a few cases of severe growth retardation. Most of
these phenotypes were present in all WT strains tested, but
with clearly different frequencies (Figure 1A).
Higher survival rates and lower frequencies of develop-
mental malformations were achieved by initiating treatment
with the same doses but later in development, 50% epiboly
(5.25 hpf). Many of the elicited phenotypes were milder and
transient, like growth delay, ﬁn-fold defects, or mild heart
oedemas mostly with normal morphology and circulation.
These embryos were generally indistinguishable from sibling
controls by 5 d postfertilization (dpf). Notochord folds were
noted but heart looping was unaffected. These phenotypes
were again shared by most strains tested, albeit at slightly
different frequencies. The penetrance of these common
phenotypes in each strain was apparently decreased com-
pared to earlier treatment (Figure S1). In agreement, these
drug doses had no adverse developmental effects when
treatment was initiated at 75% epiboly (8 hpf). We assessed
the molecular events elicited by initiating treatment at 50%
epiboly with the indicated drug doses by monitoring heat
shock protein 70 (Hsp70) levels in treated embryos. Hsp70
was not induced at any of the inhibitor doses tested (Figure
2A). Hsp90 functional reduction was conﬁrmed by monitor-
ing the Hsp90 client protein RAF1, whose levels decrease with
Hsp90 inhibition in a dose-dependent manner (Figure 2B)
[39]. Although this gives an indirect estimation of Hsp90
inhibition, the residual presence of RAF1 protein, even at the
highest inhibitor dose used, demonstrates that only partial
Hsp90 functional reduction was elicited.
Morpholinos are injected at two to four cell stage, which
decreases Hsp90 protein levels at earlier developmental
stages than the selected conditions for chemical treatment;
but doses that do not give rise to severe phenotypes when
injected into WT embryos still help to validate chemical
inhibition studies. Injecting the double morpholino knock-
down (Hsp90 aþb: 6 ng of hsp90a and 6 ng of hsp90b) partially
decreased Hsp90 protein levels (Figure 2C) and had no
noticeable effect on embryos derived from the WT strains
Golden (n ¼ 71). Higher doses occasionally produced heart
defects, such as inverted looping (Golden: 4/100) (Figure 1O)
or no looping (WIK: 5/36) (Figure S2A), oedema (Golden: 10/
100 and WIK: 0/36), and notochord defects (Golden: 2/100 and
WIK: 0/36), but also decreased viability (Golden: 40/100). The
low frequency of heterotaxia is in agreement with our
observation that trait penetrance decreases when Hsp90
function is chemically reduced before 30% epiboly (unpub-
lished data). Doses above 10 ng of each morpholino (Hsp90
aþb) almost completely erased Hsp90 protein, greatly
reducing viability, with severe oedema in most embryos (17/
20 injected) (Figure S2B). While the speciﬁc chemical
inhibitors reduce the functional capacity of Hsp90 without
decreasing Hsp90 protein levels, in morpholino-injected
embryos Hsp90 levels were reduced in a dose-dependent
manner with the consequent Hsp70 induction and decreased
RAF1 levels (Figure 2C).
The two chemically unrelated drugs and morpholino knock
down produced an overlapping spectrum of phenotypes,
showing different frequencies and severities that may be due
to differences in drug metabolism (between radicicol and
17AAG) [40–41], or treatment timing (between drugs and
morpholino). Most of the phenotypes observed by initiating
drug treatment at 30% epiboly were shared by all strains
tested but revealed at different frequencies and therefore
represent Hsp90 buffering of common gene variants or
polymorphisms presumably present in different strain
speciﬁc combinations. Treatment timing was critical for the
penetrance of these traits.
Importantly, when drug treatment was initiated at 50%
epiboly, rather than 30%, there was no signiﬁcant impair-
ment of development in embryos derived from WT strains.
The selected drug concentrations reduce Hsp90 functional
activity without inducing a heat shock response, which could
obscure the effect of Hsp90 reduction during development.
Consequently, to investigate the effect of Hsp90 phenotype
Table 1. Zebrafish Strains Used in This Study
Strains Origin Mutated Gene Original Phenotype
WIK Wild WT –
*AB Wild WT –
Tuebingen Wild WT –
Golden Wild SLC24A5
a Reduced pigmentation
Albino Wild alb Reduced pigmentation
syu ENU shh (stop) U-shaped somites
yot ENU gli2 (stop) U-shaped somites
sri ENU pax6b (missense)
b Lens, eye size
dre ENU sufu (missense) [42] Lens, eye size
AMN ENU Unknown Eye, axis duplication
WT strains were originally obtained from the Zebrafish International Resource Centre [80].
Mutant strains were isolated from the Tuebingen ethylnitrosourea mutagenesis screen
[79].
aPigment mutation [82].
bR.M. Bancewicz, unpublished.
AMN is a previously cryptic trait, independent of the gli2 mutation but found only in fish
derived from the yot mutant strain.
doi:10.1371/journal.pgen.0030043.t001
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epiboly with doses of 10 lM radicicol or 3.3 lM 17AAG, or
lower, so minimizing the potential appearance of common
developmental defects by narrowing the developmental
window for the perturbation.
Hsp90 Modifies the Severity of Mendelian Eye Mutants
Variable severity, age of onset, and intrafamilial variability
are often observed in classical Mendelian monogenic diseases.
In order to investigate possible factors that could alter the
phenotypic outcome of simple traits, we assessed the effect of
Figure 1. Developmental Defects Observed among WT Strains after Decreasing Hsp90 Function at 30% Epiboly
(A) Frequencies: Embryos were treated at 30% epiboly with 10 uM radicicol (blue) or 3.3 lM 17AAG (orange). Rate of survival is the relative percentage
of live embryos at 48 hpf compared to the relevant control siblings. Abnormal heart looping includes heterotaxia and nonlooping of the heart tube;
severely oedematous fish with consequently abnormal heart were excluded.
(B–O) Examples of observed phenotypes: (B–D) Developmental delay observed at 24 hpf after treatments. Interrupted caudal fin fold (dotted lines) after
radicicol (E) or 17AAG (F) treatment. Notochord folds (arrows) after radicicol (G) and 17AAG (H). Drug-induced heart oedema with abnormal heart
morphology after radicicol (I) and 17AAG (J). Radicicol-induced mild oedema with abnormal heart looping (K). WT (L) or inverted heart looping after
17AAG (M), radicicol (N), or Hsp90 morpholino injections (O). Black arrows indicate the position of the ventricle.
doi:10.1371/journal.pgen.0030043.g001
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sunrise (sri) and dreumes (dre) (Table 1).
The pax6b mutant sri (R.M. Bancewicz, unpublished data)
and the sufu mutant dre (Table 1) [42] both show abnormal
lens development (Figure 3) [43], with complete penetrance
but variable severity [1]. This is demonstrated by a decrease in
lens size relative to the retina (Figure 3B and 3C) reﬂecting
abnormal development of surface ectoderm-derived struc-
tures [44]. Occasional failure to close the optic ﬁssure
(coloboma) is also observed (Figure 3D). Upon Hsp90 func-
tional reduction, lens size relative to the area of the retina
was signiﬁcantly decreased in homozygous sri embryos while
homozygous dre remained unaltered (Figure 3I; Table 2). Lens
shape was signiﬁcantly altered in both homozygous mutants
(Figure 3J; Table 2); but while in treated sri embryos the lens
became more elliptical, in treated dre embryos it became
more circular, more closely resembling lens shape in WT ﬁsh.
A 3-fold increase in the frequency of colobomas was also
observed among treated homozygous sri embryos (p , 0.021),
while in treated dre embryos a slight decrease was seen (1.6%
versus 0.4%). These results show that decrease in Hsp90
functional capacity can signiﬁcantly inﬂuence the expressiv-
ity of Mendelian traits in a way that is clearly dependent on
the genetic background.
The signiﬁcant effect of Hsp90 inhibition on the sri
background prompted us to investigate whether dominance
relationships could be altered in vertebrates, as previously
observed in Drosophila and Arabidopsis [7]. Notably, in
heterozygous sri embryos and in an additional genetically
unrelated strain (AMN strain) (Table 1), these parameters
were unaffected by the drug treatment (Table 3). The
different susceptibility of homozygous and heterozygous sri
embryos demonstrates that the increased phenotypic severity
in homozygotes is due to the synergistic effect between
decreased Hsp90 function and the homozygous mutant
phenotype rather than to additive effects between reduced
Hsp90 function and increased dose of the mutant Pax6b
protein.
Factors That Contribute to Phenotype Modification by
Hsp90 Inhibition
The observation that both lens size and shape can be
affected in sri derived embryos but only lens shape was
altered in dre embryos suggests that the two developmental
processes can be uncoupled. As described above, Hsp90
chemical inhibition by the structurally distinct drugs radi-
cicol or 17AAG signiﬁcantly reduced lens size and worsened
lens eccentricity of sri homozygous embryos (Table 4).
Geldampicin (GMP), a structurally related but inactive form
of 17AAG, was used as a negative control to discount direct
drug toxicity as the mechanism for this phenotype modu-
lation [45]. GMP had no effect on these parameters (Table 4).
We then decreased Hsp90 activity with the combined
morpholinos: Hsp90 aþb. Coinjecting 6 ng of each morpho-
lino signiﬁcantly affected lens size without altering lens shape
(Table 4), conﬁrming that the two developmental processes
can be uncoupled. Hsp90 can also be diverted from its
developmental role by the induction of a generalised stress
response [46]. Brief heat exposure of homozygous sri mutants
also resulted in altered phenotypic severity not observed in
control siblings (Table 4). Interestingly, lens size and shape
were affected by heat shock, but in contrast to Hsp90
chemical inhibition, lens shape was ameliorated instead of
worsened (compare t-values, Table 4). Several factors may be
contributing to these phenotypic outcomes: functional
reduction of Hsp90 by these treatments may be milder than
Hsp90-speciﬁc chemical inhibition. This seems likely as RAF1
levels observed after morpholino injections are comparable
to those seen in control embryos, despite the reduced Hsp90
protein levels (6 ng Hsp90 aþb, Figure 2C). Higher morpho-
lino doses drastically reduced RAF1 levels but mostly
produced severely oedematous embryos whose eyes could
not be analysed. More signiﬁcantly, we observed a positive
correlation between Hsp70 levels and amelioration of the
lens eccentricity (6 ng Hsp90 aþb, Figure 2C; Hsp70 levels,
Table 4). Hsp70 is constitutively expressed during normal lens
development from 28 hpf [47]. Earlier induction by heat
treatment or morpholino knock down may contribute to the
partial rescue of the sri lens phenotype, in contrast to drug
treatment conditions that were speciﬁcally selected to avoid
inducing a heat shock response. Heat shock also induces
Hsp90 expression, and this may contribute additional
capacity to cope with the increased requirement for
chaperone activity following heat shock.
Mendelian Mutants Resistant to Mild Hsp90 Functional
Reduction
To address how commonly Hsp90-mediated release of
genetic variation is observed, we selected Mendelian mutants
that affect somitogenesis, a developmental process previously
found to require the chaperone function of Hsp90 [37,48].
Figure 2. Assessment of Heat Shock Induction and Levels of Hsp90
Inhibition
(A) Western blots to assess Hsp70 induction following overnight
treatment of WT embryos initiated at 50% epiboly with increasing
concentrations of radicicol or 17AAG. As positive control, Hsp70 was
induced by incubating embryos at 37 8C for 30–60 min before
harvesting.
(B) Western blots showing graded reduction in RAF1, an Hsp90 client-
protein, in response to inhibition by radicicol and 17AAG.
(C) Western blots to assess Hsp90, Hsp70, and RAF1 levels in embryos
injected with 6 ng of universal morpholino control (STD MO) or Hsp90
aþb morpholinos at the indicated individual amounts. a-tubulin was
used as loading control.
*, Nonspecific band showing equal loading
doi:10.1371/journal.pgen.0030043.g002
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mutants.
We studied the semidominant you-too (yot) mutant, with U-
shaped somites, carrying a premature protein truncation
mutation in the gli2 gene (Table 1) [49]. Although live
heterozygous yot embryos are indistinguishable from wild
type, histological analysis had shown a reduction in the MyoD
expression [50]. Murine MyoD has been previously identiﬁed
as an Hsp90 client protein [51], which dissociates from the
cochaperone cdc37 in the presence of GA potentially
interfering with myoblast differentiation programs [52]. The
homozygous yot phenotype is fully penetrant with variable
severity. Hsp90 inhibition did not signiﬁcantly worsen the
homozygous phenotype of yot embryos (unpublished data),
nor were somite defects uncovered when heterozygotes were
treated with radicicol. Thus Hsp90 functional reduction had
no effect on the gli2 pathway in spite of the already
compromised low levels of MyoD protein.
The phenotypically variable, recessive somite mutant sonic-
you (syu) with a stop codon mutation in the sonic hedgehog gene
shh [53] was also unaffected by Hsp90 inhibition (unpublished
data). Thus, mild perturbation of Hsp90 function does not
affect all Mendelian phenotypes during vertebrate develop-
ment emphasizing the selective interplay between Hsp90
buffering and the underlying genotype.
Hsp90 Functional Reduction Reveals Previously Cryptic
Eye Trait
During our studies of the yot mutant strain, radicicol
treatment revealed novel eye phenotypes not previously
described in heterozygous or homozygous embryos of this
Figure 3. Assessing Range of Expressivity and Quantifying Phenotype Modulation in sri and dre Strains
(A–H) Phenotype of the sri and dre eye mutants at 5 dpf. (A–D) Lateral view of live embryos; (E–H) histological sections. (A) WT; lens (white-dotted lines)
and retina (red-dotted lines) measurements were used to asses phenotypic severity; (E) WT section showing retina (re), lens (le), cornea (co); (B) and (F)
sri mild and (C) and (G) sri severe; (D) dre with coloboma (cb); (H) dre showing flattened anterior segment.
(I and J) Ranked plots showing distribution of quantitative eye parameters in treated (white circles) and sibling control (black circles) homozygous
embryos: (I) Ratio of retina to lens area; (J) Lens shape or eccentricity.
doi:10.1371/journal.pgen.0030043.g003
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anophthalmia to unilateral microphthalmia (Figure 4), were
never observed in three other tested mutants, syu, dre, or sri
(Table 1). Molecular analysis proved these eye defects to be
independent of the gli2 mutation in the yot strain, and the yot
genotype and phenotype were rapidly lost from carriers of
this new variable eye trait, named AMN for anophthalmia,
microphthalmia, and nanophthalmia.
In seven yot-derived mated pairs, from a total of 24, partial
Hsp90 inhibition repeatedly gave rise to affected offspring;
these were designated transmitter parents for the AMN eye
trait (P0, Figure 5; Table 5). Their offspring revealed a
signiﬁcant increase in the frequency of developmental eye
phenotypes compared to those from nontransmitter pairs
and from genetically unrelated WT strains (Table 5). AMN-
like defects were not induced repeatedly in any other mutant
or in WT strains tested (n . 3,000), where even higher
inhibitor doses (10 lM radicicol or 3.3 lM 17AAG and Hsp90
morpholinos) or earlier treatment (at 30% epiboly) were
ineffective (Multiple Unrelated Strains, Table 5; unpublished
data). Except for two embryos among several thousand
scored, whenever eyes were affected in WT-treated stocks, it
was in the presence of other more severe defects like oedema
or incomplete development. These occasional abnormal
phenotypes do not recur in subsequent generations and their
frequency was unaltered by Hsp90 inhibition; they were not
counted in the analysis (Multiple Unrelated Strains, Table 5).
Where reduced Hsp90 function repeatedly reveals increased
frequency of offspring with a particular phenotype, it is
deemed to be uncovering a previously cryptic mutation in
susceptible populations (Parental Transmitters, Table 5).
Unlike abnormal heart looping, notochord, or ﬁn-fold
defects, the AMN phenotype was revealed uniquely in the
yot population. Hsp90 inhibition therefore uncovers cryptic
phenotypes selectively in susceptible populations, during
vertebrate development.
Complex Inheritance Patterns of Cryptic Trait
The low viability of AMN-affected embryos means that
most of the offspring raised for subsequent breeding were
phenotypically WT. From these, 11 females were crossed to 15
males in 21 different combinations. Half of the pairs
transmitted the AMN trait, albeit at greatly different
frequencies (0.5%–13%) in the absence of Hsp90 inhibition.
This suggests a genetic basis involving several loci, some of
which are required to be homozygous. Highly variable
frequencies of affected offspring in different batches of eggs
from the same mating pair demonstrate the variable
penetrance of the trait. Additional rare phenotypes like
cyclopia (fused central eye) (Figure 4D; Tables 5 and 6) and
posterior body-axis duplications (Figure 4G) reappeared after
inbreeding (Table 6). Some offspring showed novel pheno-
types such as nanophthalmia (small eyes with normal
structure) and anterior body-axis duplication (Figure 4C
and 4F), indicating that different recessive interacting loci are
brought together at an early stage following inbreeding. The
almost continuous range of phenotypes conforms to a
threshold model [56] where several modiﬁers are required
to interact genetically with a primary recessive mutation to
Table 2. Quantitative Effect of Hsp90 Inhibition on Embryos Derived from Eye Mutants
Strain Treatment Number of Eyes Retina Area/Lens Area Lens Eccentricity
Mean SD p-Value t-Value Mean SD p-Value t-Value
dre ( / ) Ethanol 122 8.45 1.40 No significance 0.49 0.11 ,0.001 þ3.56
Radicicol 140 8.51 1.47 0.44 0.11
sri ( / ) Ethanol 35 7.27 0.69 ,0.001  7.37 0.37 0.10 ,0.001  3.90
Radicicol 35 10.66 2.63 0.49 0.14
Eye measurements (Materials and Methods) were compared by two sample t-tests assuming unequal variances. Drug doses were: ethanol (0.04 %) and radicicol (10 lM). Treatment was
initiated at 50% epiboly.
SD, standard deviation
doi:10.1371/journal.pgen.0030043.t002
Table 3. Synergistic Effect of HSP90 Inhibition and Homozygous sri Phenotype
Strain Treatment Number of Eyes Retina Area/Lens Area Lens Eccentricity
Mean SD p-Value t-Value Mean SD p-Value t-Value
sri ( / ) DMSO 50 8.58 0.78 ,0.001  5.10 0.42 0.12 ,0.001  5.10
17AAG 49 9.65 1.25 0.47 0.09
sri (þ/ ) DMSO 105 7.09 0.52 No significance 0.357 0.09 No significance
17AAG 104 6.96 0.56 0.355 0.11
AMN
a DMSO 46 6.66 0.47 No significance 0.376 0.11 No significance
17AAG 47 6.61 0.39 0.343 0.09
Drug doses: DMSO (0.03%) and 17AAG (2.5 lM) added at 50% epiboly.
aAMN-derived phenotypically WT embryos.
SD, standard deviation
doi:10.1371/journal.pgen.0030043.t003
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interactions will be further illustrated by divergent responses
to Hsp90 inhibition (see below).
The inbreeding regime maintained the complex eye trait
for at least ﬁve generations but never ﬁxed it at Mendelian
frequencies, most likely because only phenotypically unaf-
fected individuals could be mated (Inbreeding, Figure 5). The
low frequency of AMN defects observed in subsequent
generations is another indication of the oligogenic nature
of the trait. Nevertheless, the sensitivity to reduced Hsp90
levels remains. Female transmission of the AMN trait was
observed after outcrossing phenotypically WT F1 carrier
females to genetically unrelated WT males (F2, Female
Outcross, Figure 5) with variable frequencies. The affected
individuals derived from these outcrosses were viable and
fertile, suggesting loss of some deleterious modiﬁers. How-
ever, the phenotype was not observed in the generation
arising from these affected sibling crosses (F3, Female
Outcross, Figure 5), but it was recovered after further
inbreeding (F4, Female Outcross, Figure 5). This inheritance
pattern is consistent with a requirement for a maternal
recessive component with partial penetrance. In contrast,
when selected males were outcrossed to genetically unrelated
WT females, AMN-like embryos were not observed initially
(F2, Figure 5, Male Outcross). However, AMN-like embryos
were recovered in the ﬁrst generation of subsequent
inbreeding (F3, Male Outcross, Figure 5) suggesting that
homozygosity of a recessive zygotic component is required.
The recessive genetic basis of the AMN trait, suggested by
these inheritance patterns, does not exclude the possibility
that additional genetic or epigenetic modiﬁers also affect the
severity and/or penetrance of the AMN phenotype.
Hsp90 Inhibition Reveals Digenic Nature of the AMN Trait
Although all transmitting females tested produce some
affected offspring upon outcrossing to an unrelated WT male,
treatment of embryos from these pairs revealed two types of
AMN transmitter females: Two inbred F1 females crossed to
Table 4. Morphological and Quantitative Components Are Differentially Buffered by Hsp90
sri ( / ) Treatment Number of Eyes Retina Area/Lens Area Lens Eccentricity (Shape)
Mean SD p-value t-value Mean SD p-value t-value
Ethanol 35 7.27 0.69 ,0.001  7.37 0.37 0.10 ,0.001  3.90
Radicicol 35 10.66 2.63 0.49 0.14
GMP 35 7.49 1.47 ,0.001  4.30 0.34 0.11 0.029  2.24
17AAG 35 9.71 2.67 0.41 0.16
STD Mo 67 8.15 0.84 ,0.001  4.42 0.36 0.10 No significance
Hsp90 aþb 66 9.07 1.47 0.34 0.09
Untreated 35 7.85 0.84 0.005  2.90 0.41 0.09 0.027 þ2.26
Heat shock 35 8.56 1.17 0.36 0.08
Drug doses: ethanol (0.04%), radicicol (10 lM), GMP (2.5 lM), and 17AAG (2.5 lM) added at 50 % epiboly. Injections comprised 6 ng of universal standard control morpholino or 6 ng each
of the two morpholinos Hsp90 aþb (12 ng total). Heat shock response was induced by incubating sri embryos for 30 min at 37
8C at 50% epiboly. In all cases eye measurements were taken
at 5 dpf.
SD, standard deviation
doi:10.1371/journal.pgen.0030043.t004
Figure 4. Eye Defects and Body-Axis Duplications Observed in AMN Population
Dorsal views shown are: (A) Unilateral anophthalmia; (B) Unilateral microphthalmia; and (C) Unilateral nanophthalmia (UN), illustrating retina (re), lens
(le), cornea (co). (D) Ventral view of cyclopic embryo is shown. (E) Bilateral anophthalmia is shown (top, lateral view; bottom, dorsal view). (F) Anterior
body-axis duplication (ABD), two complete heads formed; incomplete ABD were also observed (not shown). (G) Posterior body duplication (PBD), two
notochords showing adjacent somite boundaries (arrows), culminating in two tails.
doi:10.1371/journal.pgen.0030043.g004
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frequency of AMN offspring when embryos were treated with
17AAG (Figure 6; Group 1, Table 6). In contrast, three inbred
females from F1 to F5 crossed to seven different males
produced fewer AMN-affected embryos with 17AAG treat-
ment than without (Figure 6; Group 2, Table 6). Both Group 1
and male transmission frequencies of AMN are also increased
when Hsp90 inhibition is elicited by morpholino injections
knocking down hsp90a and hsp90b (n injected ¼ 154;
frequency, 10%; p ¼ 0.02). Once more, these results
demonstrate that partial inhibition of Hsp90 function can
increase as well as decrease phenotypic penetrance of disease
traits and further suggest that at least two segregating loci are
involved in the original AMN phenotype.
Components of the Canonical Wnt Pathway May Underlie
the AMN Complex Trait
Anterior and posterior body duplications were also
observed in the offspring of Group 1, but not Group 2
females. The copresentation of axis duplication with cyclopia
or absent eyes is reminiscent of phenotypes caused by
alterations in the canonical Wnt signalling pathway [58–60].
To test this suggestion, embryos derived from both groups of
females were treated for ﬁve minutes with lithium chloride, a
glycogen synthase kinase 3b inhibitor that mimics Wnt
signalling [59,61]. At the selected doses and incubation times,
embryos derived from WT strains, or from Group 2 females
incrossed to AMN transmitting males, were barely affected
(Figure 7) [59]. In contrast, lithium-treated embryos from
Group 1 females outcrossed to genetically unrelated WT
males show a signiﬁcant increase in the number of eye defects
compared to their untreated siblings (n ¼ 47; p ¼ 0.001)
(Figure 7). Genes from the canonical Wnt pathway may,
therefore, be implicated in the genesis of the eye trait in
Group 1.
In agreement with the contrasting phenotypic outcomes
following Hsp90 inhibition in embryos derived from Group 1
and Group 2 females, these results indicate that the original
AMN trait comprises at least two loci sensitive to Hsp90
ﬂuctuation. Recombining of variant alleles at these seemingly
antagonistic loci may explain the sudden rise in the frequency
of AMN from parental to F1 generation, observed in some of
the crosses.
Modulation of Developmental Stability in Vertebrates by
Hsp90
Symmetry of bilateral traits is often used as a parameter for
developmental stability [62]. Measures of developmental
instability include nondirectional quantitative deviation from
bilateral symmetry, also called ﬂuctuating asymmetry. Other
asymmetric manifestations include unilateral absence of
organ structures and perturbed organ distribution across
the left-right axis or phenodeviants [63].
Figure 5. Inheritance Patterns of AMN
AMN parental carriers were crossed and the subsequent generations
raised following inbreeding or outcrossing to genetically unrelated WT
mates (white symbols, phenotypically WT fish; black symbols, AMN
affected fish; squares, males; circles, females). Line across black symbol
indicates lethality of affected phenotype. Outcrosses showed two types
of transmission: maternally determined (female outcross) and zygotically
determined (male outcross) trait. After inbreeding, only WT embryos
were viable. After outbreeding, some affected embryos were viable and
fertile. The mating of affected fish produced only WT embryos illustrating
the requirement for genomic homozygosity at some locus/loci in the
oocyte (female outcross). Most carrier pairs transmitted the trait at a
frequency of 0.5%–5%. For the few high-transmitting parents, the
frequency of affected embryos without treatment was never greater
than 13% in any one cross.
doi:10.1371/journal.pgen.0030043.g005
Table 5. Frequency of Eye and Body-Axis Defects in Parental AMN and WT Strains
Strains Treatment Unilateral Bilateral AMN frequency p-Value Cyclopia ABD PBD
Unaffected parental transmitters of eye traits (seven pairs) Ethanol 1 2 0.45% (3/664) 0.011 1 0 0
Radicicol 3 10 2.00% (13/641) 3 0 2
Unaffected parental nontransmitters (17 pairs) Ethanol 0 1 0.26% (1/372) Not significant 0 0 0
Radicicol 0 0 0% (0/303) 0 0 0
Multiple unrelated strains Ethanol 0 1 0.05% (1/1787) Not significant 0 1 0
Radicicol 0 0 0% (0/2411) 0 0 0
Data represent the combined results of several spawning treated at 50% epiboly with different drug doses. For each egg lay siblings are split between solvent controls or treated. Parental
carriers of AMN emerged from crosses of heterozygous yot to WT fish. Parental generation (P0) fish were assigned to transmitter or nontransmitter groups based on whether they give rise
AMN embryos after Hsp90 inhibition. Golden and WIK strains were used as genetically unrelated WT fish, to determine the background frequency of sporadic and drug induced defects.
Drug doses: ethanol (0.0004%–0.004%), radicicol (1.6 and 10 lM), DMSO or methanol (0.016%, 0.03%, and 0.04 %), GMP (2.5 lM), and 17AAG (1.4, 2.5, and 3.3 lM).
ABD, anterior body-axis duplication; PBD, posterior body duplication
doi:10.1371/journal.pgen.0030043.t005
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unilaterally affected eyes (mostly anophthalmia) in embryos
from AMN females following Hsp90 functional reduction by
inhibitor treatment or morpholino knock down (Table 7).
Similarly, we observed a signiﬁcant increase in the number of
unilateral colobomas among sri-treated embryos (Table 7)
The relative increase in the frequency of unilateral morpho-
genic events between controls and treated embryos, suggests
that Hsp90 can buffer developmental stability in vertebrates.
Inverted cardiac looping could be considered as another
indication of compromised homeostasis during development.
When 17AAG treatment is initiated at 30% epiboly we
observed a dose-dependent increase in the frequency of
heart-loop reversal or heterotaxia in WT strains (Figure 8A).
Interestingly, at the same dose (2.5 lM 17AAG) the frequency
of induced heterotaxias is higher in embryos from mutant
strains like sri or AMN than in WT strains (incrosses, Figure
8B and 8C). When these carrier ﬁsh are outcrossed to WT
strains, heterotaxia frequencies are signiﬁcantly decreased
(outcross, Figure 8C), suggesting that increased susceptibility
to heterotaxia may be associated with homozygosity at
predisposing loci. Alternatively, a previous unrelated muta-
tion, which would not contribute to the trait under normal
circumstances, could compromise development, rendering it
more susceptible or dependent on fully functional buffering
mechanisms like Hsp90.
Previous work has shown that in Drosophila, Hsp90 does not
affect the ﬂuctuating asymmetry of quantitative traits [64]. In
contrast, Hsp90 can buffer stochastic processes in normal
plant development [8]. Given the impact of Hsp90 reduction
on the unilateral appearance of anophthalmia and coloboma
among treated individuals over their sibling controls in some
of our ﬁsh strains, we investigated whether Hsp90 could
increase intraindividual quantitative differences in these
mutants. Surprisingly, although Hsp90 reduction signiﬁcantly
affects the severity of lens defects in sri mutants (Table 3), it
did not alter the variation between left and right measure-
ments of any of these quantitative parameters (Table 8). Thus,
as in Drosophila, under our experimental settings and
statistical methods, Hsp90 plays no role on the developmental
stability of quantitative traits. In contrast, Hsp90 clearly alters
the consequences of stochastic processes on morphogenic or
qualitative threshold traits like AMN, coloboma, and heart
looping.
Hsp90 Can Modulate Phenotypes by Selective
Chaperoning of Mutant Proteins
In order to understand phenotypic modulation of mutant
phenotypes by Hsp90, we investigated the effect of compro-
mised Hsp90 function on WT and sri mutant Pax6b proteins.
Initial studies assessed the response of transfected WT and
mutant expressed proteins to Hsp90 inhibitors. The sri
mutation is expected to disrupt the folding of the homeo-
domain that contains it (R.M. Bancewicz, unpublished data).
Immunohistochemical studies show that while WT Pax6b
protein remains mostly unaffected, the levels of Pax6b
mutant protein are signiﬁcantly decreased when Hsp90
function is impaired by 17AAG treatment (Figure 9). The
Table 6. Two Classes of AMN Transmitter Females Identified
Class Treatment Unilateral Bilateral Cyclopia Frequency p-Value ABD PBD
Group 1: increased penetrance upon Hsp90
reduction (two females, F1)
Controls 5 5 1 12.5% (11/88) 0.009 0 2
17AAG 19 9 1 27.6% (29/105) 0 1
Group 2: decreased penetrance upon Hsp90
reduction (three females, F1 to F5)
Controls 4 1 1 4.18% (11/263)
a 0.037 0 0
17AAG 1 1 0 0.76% (2/262) 0 0
Data represent the combined results of several spawning treated at 50% epiboly with different drug doses. For each egg lay siblings are split between solvent controls or treated. Parental
carriers of AMN emerged from crosses of heterozygous yot to WT fish. In subsequent generations, two groups of females were defined based on the opposing effects of Hsp90 reduction
on AMN penetrance in embryos derived from outcrossing the females to males derived from WT Golden or WIK strains: Group 1 with increased frequency and Group 2 with decreased
frequency of affected embryos after treatment. Phenotypes are grouped according to whether one (unilateral) or both (bilateral) eyes are affected.
Drug doses: ethanol (0.0004%–0.004%), radicicol (1.6 and 10 lM), DMSO or methanol (0.016%, 0.03%, and 0.04 %), GMP (2.5 lM), and 17AAG (1.4, 2.5, and 3.3 lM).
aNot all affected embryos were classified as unilateral or bilateral but still counted as affected, totals are therefore greater than the sum of each category.
ABD, anterior body-axis duplication; PBD, posterior body duplication
doi:10.1371/journal.pgen.0030043.t006
Figure 6. Schematic Representation of AMN Phenotype Inheritance and
Susceptibility to Hsp90 Reduction
Embryos were treated with the solvent control (CN) or with radicicol
(TR1), 17AAG (TR2) or Hsp90 aþb morpholino injection (TR3). Following
Hsp90 inhibition, embryos derived from group 1 (G1) females showed
increased penetrance, while those from Group 2 females (G2) had
decreased penetrance of AMN phenotype.
doi:10.1371/journal.pgen.0030043.g006
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Hsp90 Modulates Phenotype in Vertebratesdecreased stability of the mutant protein suggests that it
requires Hsp90 for maintenance in a stable conformation.
The differential sensitivity of mutant and WT proteins when
Hsp90 function is compromised provides a molecular
explanation for the worsening of the sri phenotype upon
treatment. pax6a and pax6b in zebraﬁsh are the paradigm
model for subfunctionalisation by differential distribution of
long-range control elements (D. Kleinjan, personal commu-
nication). The nonoverlapping expression pattern of the two
Pax6 isoforms leads to the lens-speciﬁc phenotype of the sri
mutant and to the worsening of this phenotype when
chaperone function is inhibited.
Discussion
Development is surprisingly robust to environmental,
genetic, and stochastic variation. How the integration of
multiple pathways, acting in narrow developmental windows,
culminates in morphologically constant phenotypes is the
subject of continuing debate. At the molecular level, genome
duplication along with increasing complexity of epigenetic
codes, chromatin regulation, and genomic organisation have
led to increased compartmentation and subfunctionalisation,
and to an improved capacity to absorb and buffer genetic
variation. However, the underlying variation and phenotypic
plasticity can be exposed by perturbing the buffering systems
(reviewed in [65–66]). Modulating Hsp90 function is one
mechanism that has been shown to reveal cryptic variation.
Unravelling the mechanisms of variability in heritable
phenotypes is important for understanding disease predis-
position and penetrance. Here we show how vertebrate
phenotype can be modulated by the chaperone Hsp90 and
start to decipher the molecular underpinnings of this
buffering mechanism.
Fine-tuning the titration and timing of Hsp90 functional
reduction allowed us to demonstrate that Hsp90 is also able
to buffer hidden genetic variation in vertebrates. The
common phenotypes, revealed at different strain-speciﬁc
frequencies in WT stocks, may represent common poly-
morphisms present in the available ﬁsh populations at several
Figure 7. Sensitivity of Group 1 Embryos to Lithium Chloride: An Inducer of Wnt Signalling
(A) Assessing duration of LiCl treatment that would not significantly affect embryos from WIK and Golden strains.
(B) LiCl treatment (0.3 M for 5 min) of embryos from Group 1 females outcrossed to WIK males gave rise to increased frequency of eye defects, while
embryos derived from Group 2 females crossed to WT (not shown) or AMN transmitting males did not.
doi:10.1371/journal.pgen.0030043.g007
Table 7. Compromised Hsp90 Function Increases the Relative
Frequency of Discrete Asymmetric Individuals
Trait Hsp90 Unilateral Bilateral Total Asymmetry
Relative
Frequency
a
AMN
b Control 15 21 502 41%
Reduced 38 28 549 57%
Coloboma
c Control 11 3 177 78%
Reduced 22 3 150 88%
Data represents the combined results of several independent experiments, where Hsp90
was either chemically inhibited or reduced by morpholino knock down.
aRelative frequency of asymmetry calculated as the percentage of unilateral to the total of
affected individuals.
bEmbryos derived from AMN strains: the affected embryos have either anophthalmia or
microphthalmia. Cyclopia is considered bilateral.
cNumber of colobomas among embryos from sri homozygous parents.
doi:10.1371/journal.pgen.0030043.t007
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Hsp90 Modulates Phenotype in Vertebratesdifferent possibly interacting loci, suggesting Hsp90 buffering
may be responsible for canalising polygenic traits present in
noninbred populations. Delaying treatment timing decreased
the penetrance of these shared phenotypes and revealed the
role of Hsp90 in rare malformations, now dependent on
unique strain-speciﬁc mutations. Reducing Hsp90 function,
within the relevant developmental window, generally in-
creased the frequency of abnormal phenotypes such as
anophthalmia and microphthalmia, and it altered the severity
of some, but not all, Mendelian phenotypes studied. The
resistance of some Mendelian mutants and the opposing
(worsening versus amelioration) responses in those suscep-
tible to Hsp90 ﬂuctuation demonstrate that vertebrate Hsp90
buffering is a highly selective mechanism, modulating only
deﬁned genetic components of phenotypic variation. The
recessive nature of the susceptible alleles characterised in this
study suggests that the higher frequency and broader
spectrum of phenotypes uncovered in Drosophila and Arabi-
dopsis may be inﬂuenced by the relatively inbred nature of
these organisms [5,8]. Zebraﬁsh do not tolerate a high level of
inbreeding, perhaps providing a better model for generally
outbred human populations. The number of Hsp90 loci and
the different spectrum of environmental triggers may also
inﬂuence Hsp90 buffering capacity across phyla.
Opposite outcomes in the Mendelian microphthalmia
mutants sri and dre, with the same tissues affected in both,
demonstrate that Hsp90 modulation of phenotypes strongly
depends upon the speciﬁc underlying genetic components.
Despite the strong effect that Hsp90 inhibition had in sri
homozygous embryos, it had no measurable effect in
heterozygotes. This nonadditive response of the sri homo-
zygous mutants to Hsp90 ﬂuctuation conﬁrms the role of
Hsp90 in the maintenance of trait thresholds [67]. In contrast
to plants and ﬂies [7], these results imply that dominance
relationships [1] may not be alterable in vertebrates by
Hsp90—that is, previously recessive characters do not
become dominant. The severity of the sri phenotype was also
increased by heat shock. From the evolutionary point of view,
increased temperature may not be a frequent mechanism
through which Hsp90 releases variability in mammals, but
this mechanism probably underlies the observations that
maternal fever in humans and mild experimental hyper-
thermia in animals are associated with increased frequencies
of developmental malformations, both mild and severe [68–
70]. Similar adverse phenotypic outcomes may be elicited
through induction of protein-folding stress in the developing
embryo as a result of exposure to relatively low levels of
environmental pollutants, or when endogenous protein
aggregation levels are increased [71].
The uncovering of the complex AMN phenotypes focuses
attention on the role of Hsp90 in oligogenic malformations.
The involvement of multiple interacting loci, several with
recessive effect, is indicated by the requirement for inbreed-
ing, and the less than 25% peak frequency observed for AMN
phenotypes. The involvement of two distinct sets of genes,
but perhaps with overlapping functions, is suggested by the
observation that AMN frequencies may be increased or
decreased following Hsp90 inhibition in different parental
groups. These opposing responses once more underline the
complex mechanisms of interaction between developmental
alleles and Hsp90-mediated release of genetic variation. The
possibility of decreased phenotypic severity under stress
conditions (Hsp90 reduction) is potentially of great evolu-
tionary signiﬁcance.
The rapid unmasking of divergent phenotypes after Hsp90
reduction helped us to break down the AMN trait into
simpler components, indicating that this vertebrate model
system may provide a robust approach to identifying cryptic
genetic variation that can modify complex developmental
traits. Similarly, heart-loop inversion was observed after
earlier Hsp90 inhibition during development in all ﬁsh stocks
tested, but the different frequencies among WT and mutant
strains suggest underlying interacting genetic components.
Further analysis of this may permit the identiﬁcation of
Figure 8. Inversion of the Left to Right Heart Looping among 17AAG-
Treated Embryos
(A) Dose-dependent induction of heterotaxia in WT strain WIK, following
treatment at 30% epiboly.
(B) Comparison of inversion frequencies observed in the WT strains
Golden and WIK.
(C) Inbred mutant lines (sri or AMN) show significantly increased
frequency of heterotaxia compared to WT strains at the same drug
dose. Outcrossing these lines to WIK or Golden decreased the frequency
to almost WT levels.
doi:10.1371/journal.pgen.0030043.g008
Table 8. Compromised Hsp90 Function Does Not Affect
Intraindividual Quantitative Differences (p-Values)
Strain Hsp90 Retina/Lens
(Area)
Retina
(Area)
Lens
(Area)
Lens
Eccentricity
sri Control 0.230 0.679 0.074 0.101
Reduced
WT Control 0.519 0.335 0.661 0.465
Reduced
Estimation of effects on trait symmetry of functional Hsp90 reduction by ANOVA:
Logarithm of Left (L)   right (R) symmetry data were normalized to the mean trait value
within each individual jL Rj / [(LþR)/2]. Embryos with severe coloboma were excluded.
For WT strains, a t-test of the left-right difference normalized to the mean trait value
within each individual was used.
doi:10.1371/journal.pgen.0030043.t008
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Hsp90 Modulates Phenotype in Vertebratescommon susceptibility alleles at interacting loci. The obser-
vation that mutations at loci that would not normally
contribute to a certain trait (e.g., pax6b in heart looping)
may potentiate the effect of compromised Hsp90 buffering,
suggests that Hsp90 may act in concert with the organism’s
genotype. This highlights once more the different release of
cryptic genetic variation in good health and disease [72].
Our results show that in vertebrates, Hsp90 can buffer the
phenotypic variability between and within individuals of
discrete qualitative morphological traits (mainly anophthal-
mia and coloboma in this study) culminating in morpholog-
ically asymmetrical individuals. The increased frequency of
asymmetric unilateral eye defects upon Hsp90 inhibition
implies that buffering by this chaperone system contributes
to the stabilization of developmental processes that depend
on the partition of signalling molecules across body axes.
Asymmetric phenotypes could result from stochastic uneven
left/right partitioning of signalling molecules. Altered left-
right embryonic signalling can affect heart looping in a simi-
lar manner. It will be interesting to investigate how
perturbation of Hsp90 activity ampliﬁes the effect of these
seemingly stochastic events, culminating in a signiﬁcant
increase of abnormal cases. The occurrence of unilateral
and bilateral defects among AMN siblings is also strongly
reminiscent of the complex human microphthalmia, anoph-
thalmia, and coloboma spectrum [34] and indicates that
environmental and stochastic factors continue to play an
important role even when there are shared genetic compo-
nents.
We show that in vertebrates, Hsp90 can also modulate
phenotypic severity of continuous quantitative traits (e.g.,
relative lens size and lens shape in sri mutants). Surprisingly,
Hsp90 inhibition does not alter small quantitative left-right
differences of these traits, either in sri mutants or in WT
Figure 9. Differential Sensitivity of WT and sri Mutant Pax6b Protein to Hsp90 Inhibition
Cells were cotransfected with either WT or sri mutant paxb cDNA and GFP reporter. (A) Representative field of HeLa cells transfected with Pax6b-WT or
Pax6b-sri mutant immunohistochemically assessed for Pax6b protein levels (red) or control GFP frequency (green). Effects of treatment with different
concentrations of 17AAG are shown compared with DMSO control.
(B) Relative ratio of Pax6b positive (red cells) to GFP positive (green) cells for each treatment compared to the relevant DMSO control. The figures show
one representative experiment from three independent experiments with similar results.
doi:10.1371/journal.pgen.0030043.g009
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Hsp90 Modulates Phenotype in Vertebratesstrains. This raises the question of a fundamentally different
molecular basis for developmental instability of discrete and
quantitative (continuous) traits in vertebrates.
To date neither the identity of speciﬁc targets, nor the
molecular mechanisms by which Hsp90 modulates pheno-
typic expression of genetic variants at the organismal level
have been identiﬁed. The sri pax6b mutant allowed us to begin
to unravel the molecular basis of Hsp90 buffering. The
differential sensitivity of the Pax6b sri mutant protein in the
presence of Hsp90 inhibitors suggests that Hsp90 chaperones
the mutant protein; this may permit recovery of some
functionality, thereby decreasing the phenotypic consequen-
ces of the mutation. Selective degradation of mutant proteins
through Hsp90 inhibition has been documented many times
for different genes relevant for tumour progression [22]. This
de novo dependency links a previously robust trait to
environmental ﬂuctuation, rendering, in our case, eye
development more susceptible to external perturbation.
Partial penetrance of another PAX6 homeodomain mutation
(R242T) was also observed in the case of a child with
unilateral iris coloboma, whose mutation carrier mother
was completely unaffected [34]. Nonconservative missense
mutations in SUFU (orthologous to the gene mutated in the
zebraﬁsh dre mutants) have been observed in independently
isolated medulloblastomas [73] and are therefore associated
with cancer. Geographical clusters of children with eye
malformations, born to unaffected parents, and the increased
incidence of some cancers in certain areas suggest that
environmental factors may be implicated in these diseases
[74,75]. Might such factors play their role by affecting the
penetrance of underlying mutations or deleterious poly-
morphisms in susceptible individuals through diversion of
Hsp90 function? While the modiﬁable eye mutants are caused
by missense mutation, other Mendelian mutants that proved
to be insensitive to mild Hsp90 reductions were due to stop
codon mutations. We are currently investigating whether
different types of mutations (truncation versus missense) at a
single susceptible locus might have different susceptibility to
Hsp90 buffering. Missense mutations within different protein
domains (e.g., homeodomain versus paired domain in Pax6)
of susceptible proteins may also confer different basal
sensitivity to Hsp90 inhibition, as already demonstrated for
some kinases [76,77]. Similarly, might loci initially resistant to
Hsp90 ﬂuctuation become susceptible in different genetic
backgrounds?
The identiﬁcation of Hsp90-buffered genes, mutation
types, or alleles, and the structural basis of their sensitivity
to limiting chaperone capacity have important clinical
implications and will provide unique opportunities to
investigate the regulatory mechanisms involved. Our ﬁndings
open the way to the discovery of rational protective measures
that could signiﬁcantly reduce recurrence of severe devel-
opmental malformations.
Materials and Methods
D. rerio stocks. Breeding ﬁsh were maintained at 28 8Ci na
circulating water system on a 14-h light/10-h dark cycle. Embryos
were collected by natural spawning and were staged according to
Kimmel [78]. The mutants sunrise (sri), dreumes (dre), you too (yot), and
sonic you (syu) were isolated in a large an ENU mutagenesis screen [43]
and were obtained from the Tuebingen Zebraﬁsh Stockcenter [79],
together with the WT strain Tuebingen. *AB, WIK, Albino, and
Golden are commonly used WT strains and were originally obtained
from the Zebraﬁsh International Resource Center at the University of
Oregon [80]. Albino and Golden strains have mutations affecting only
melanophore pigmentation [81–82].
Mating strategies. Pair mating is between two identiﬁed individ-
uals. Incross is mating between siblings. Outcross is mating between
different mutation carriers or different strains. Mutant stocks were
maintained by alternate breeding strategies between the parental
Tuebingen strain and *AB, WIK, or Golden WT strains except for
subsequent inbreedings. All the Mendelian mutants used in this study
are recessive. sri mutants were found to be homozygous viable and
fertile, so that the Hsp90 inhibition study could be carried out using
genetically homogeneous homozygous mating pairs. Other Mendelian
mutants were studied by mating proven heterozygotes, which gave
rise to 25% affected offspring. For yot, molecular analysis was used to
conﬁrm genotype and segregation of AMN eye defects among F1
embryos. Inbreeding of AMN line was carried out for at least four
generations by successive incrossing of identiﬁed pairs that produced
AMN affected embryos with or without Hsp90 inhibition.
Treatment of D. rerio embryos with Hsp90 inhibitors and heat
shock. Embryos collected from breeding pairs were incubated in a
0.025–0.1 mg/ml solution of protease (Type1, Sigma, http://www.
sigmaaldrich.com) in system water, rinsed ten times, and partially
dechorionated. Treatment was initiated at 30, 50, or 75% epiboly [78]
and left overnight at 28 8C, followed by drug wash-out using ﬁve
rinses. Larvae were examined between 24 and 120 hpf or up to 5 dpf,
anaesthetised in a 0.1% solution of tricaine (Sigma), and immobilised
in 4% methylcellulose (Sigma) where appropriate. To avoid varia-
bility between experiments, each spawning was split in two groups,
and half was treated, while the other half was kept as its respective
control (treated only with the relevant solvent). Radicicol (Sigma) was
dissolved in 100% ethanol. GMP (gift from P. Csermely) and 17AAG
were dissolved in 100% DMSO or methanol. Surprisingly, DMSO
alone increased the penetrance of the AMN phenotype in embryos
from Group 1 females in a dose-dependent manner (unpublished
data). Increasing doses of methanol did not alter the number of
AMN-affected embryos derived from these females. Neither AMN
Group 2-derived embryos nor the unrelated sri-derived embryos have
altered penetrance or increased severity when grown in the presence
of DMSO or methanol compared to untreated siblings (Table 4). For
Group 1-derived embryos 17AAG was therefore dissolved in
methanol only. For all other mutants DMSO or methanol was used
as solvents. Some of the controls were kept untreated (no solvent
treatment and no dechorionation). Heat shock was carried out for 30
min at 37 8C in sealed petri dishes containing 30 ml system water
ﬂoated on a water bath, followed by a return to 28 8C.
Lithium treatment. Lithium treatment was initiated at the same
developmental stage as radicicol or 17AAG treatment. The embryos
were incubated at 28 8C for 5–10 min in system water with 0.3 M
lithium chloride, then washed extensively, and returned to 28 8C for
further scoring at 24–72 hpf.
hsp90 morpholino microinjection. The oligonucleotides were
obtained from Gene-Tools (http://www.gene-tools.com). The sequen-
ces used were: hsp90a, 59-TCTTTGTTGAATTATTCGCTGTATT-39;
hsp90b, 59-TCGTTGATTTTTGATGTTTTAATCG-39; Fluorescein STD
control morpholino, 59-CCTCTTACCTCAGTTACAATTTATA-39.
The morpholinos were dissolved in water at a ﬁnal concentration
of 42 ng/nl. Working dilutions were made with 1% phenol red (hsp90a
and hsp90b or STD control). Approximately 1.5 nl were injected into
the cytoplasm of two to four cell stage embryos.
Transfections and immunohistochemistry. Mammalian expression
vectors pCMV-ZfPax6b and pCMV-ZfPax6bsri, respectively contain-
ing the WT or mutant L244P version of the full-length Pax6b cDNA
(gift of Dirk Kleinjan), were used in cotransfections with the GFP
reporter pEGFP-C1 (Invitrogen, http://www.invitrogen.com). Hela
cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% calf serum (Gibco, http://www.invitrogen.
com). We seeded 10
5 cells onto 22 3 22-mm coverglass 24 h prior to
transfection. Next 200 ng of Pax6b WT or sri mutant vectors were
cotransfected with 50 ng of GFP reporter using Lipofectamine2000
(Invitrogen) as indicated by manufacturer. Lipofectamine complex
was replaced 4 h posttransfection with fresh DMEM media containing
DMSO as solvent control, or increasing doses of 17AAG. Next day,
immunohistochemistry was performed using standard methods.
Mouse monoclonal anti-Pax6 antibodies [83] and rabbit polyclonal
anti-GFP antibody (Santa Cruz, http://www.scbt.com) were used with
ﬂuorescently labelled second antibodies (Molecular Probes, http://
probes.invitrogen.com). Images were captured and compared using
IPLab. Pax6 (red) to GFP (green) ratios were calculated by manually
counting the number of red cells that appeared in the same ﬁeld as
100 green cells, at each condition. The ratio observed in Pax6b-WT
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inhibition on Pax6b proteins was calculated as the relative
percentage to each of these respective controls.
Western blotting. Lysates were prepared from 20–50 larvae
according to Westerﬁeld [84]. Bradford Protein Assay (Biorad,
http://www.bio-rad.com) was used to quantify protein levels for equal
loading and conﬁrmed by Coomassie blue staining of a duplicate gel.
Western blot analysis was carried out using standard techniques.
Speciﬁc analysis for the induction of a generalised stress response was
carried out using Hsp70 antibody from Stressgen SPA-812 (http://
www.nventacorp.com). a-tubulin monoclonal antibody TAT1 [85] was
used as loading control. RAF1 levels were detected with Abcam
ab19927 (http://www.abcam.com), a rabbit polyclonal antibody. ECL
detection with relevant secondary antibody (Amersham, http://www.
amersham.com) binding was carried out according to the manufac-
turer’s instructions.
Scoring of D. rerio mutant phenotypes. Quantitative measurements
of sri and dre were carried out using IPLab software (http://www.
scanalytics.com) on digital photographs. In sri and dre embryos eye
shape (eccentricity) was calculated as =[(major axis)
2 (minor axis)
2]/
(major axis) for the region of interest, where zero is a circle and 1 an
extreme ellipse. The axes and area were calculated automatically after
drawing around the outer edge of the retina or lens on the digital
images. The presence of coloboma was noted. Individual values and
distributions are displayed in the scatter plots (Figure 3). Mean values
and statistical results are represented in Table 3.
Cryptic developmental eye defects were revealed, initially follow-
ing Hsp90 inhibition with radicicol, among the offspring of yot (þ/ )
crossed to WT ﬁsh. Eye phenotypes were assessed in treated and
control embryos at 48–120 hpf. Carrier parents were identiﬁed based
on the repeated production of offspring with AMN-like eye
phenotypes after radicicol treatment. F1 ﬁsh are the unaffected
siblings from pair matings that produced signiﬁcant numbers of
embryos with AMN phenotypes. Some of these sibling offspring were
individually pair mated, and each spawning divided into treated and
control groups for subsequent phenotypic assessments. From F1
onwards, embryos were treated with 17AAG dissolved in either
DMSO or methanol as described above. The same analysis was also
carried out for nontransmitters derived from the yot population,
from sri and dre, as well as from the genetically distinct WT strains,
WIK, Golden, and Tuebingen (Table 2; unpublished data).
Abnormal eye structure with reduced eye size is classiﬁed as
microphthalmia (Figure 4B) and complete absence of eye as
anophthalmia (Figure 4A and 4E). Nanophthalmia is deﬁned as
normal eye structure but reduced size (Figure 4C). Each of these
mutant phenotypes was classiﬁed as unilateral (one eye affected and
one eye WT) or bilateral (both eyes equally or unequally affected). For
the assessment of developmental stability, cyclopia is considered as a
bilateral defect.
Laterality of cardiac heart looping was assessed on ventral view of
partially anesthetized 48–72 hpf live embryos under an inverted
microscope. Movies were taken of some examples of normal and
aberrant looping (see Supporting Information).
yot genotyping. Genomic DNA was extracted from whole embryos
or adult tails as described [49]. The gli2 gene was ampliﬁed by PCR
with speciﬁc primers and the product analysed by direct sequencing.
The oligonucleotides: 59-GAGCCTTAAAACTAGAATGGCCA-39 and
59-CCATCAGTGGCCATATTTTCC-39 were used as forward and
reverse primers, respectively.
Statistics. To assess the statistical signiﬁcance of the phenotypic
distribution of retina to lens ratio and shape, a two-sample t-test,
under the assumption of unequal variances, was used to compare the
means of the groups (Tables 2–4). Because of the variable penetrance
of the AMN trait in different egg lays and pairs, the effect of Hsp90
inhibition on this phenotype was calculated by combining the data
from several crosses (Tables 5 and 6) as a weighted mean of the
difference between the proportions of affected embryos in the
treated and sibling control groups over each cross. The square of this
statistic has a Chi
2 distribution with one degree of freedom. For
lithium susceptibility studies, a two-tailed unpaired Fisher’s exact test
was used to assess whether differences between solvent control and
treated siblings were signiﬁcant (Figure 7). Frequency of heart-loop
inversion was analysed by Chi
2 test with one degree of freedom
(Figure 8). For developmental stability of quantitative eye traits in
WT strains, a two-tailed unpaired Fisher’s exact test was used to assess
whether differences in left and right measurements between control
and treated siblings were signiﬁcant. For sri-derived embryos an
ANOVA analysis of the logarithm of the absolute difference of the
left and right measurements normalized to the mean trait value
within each individual was corrected for batch and presence of
coloboma and used to asses difference between control and treated
siblings ( j log10(L   R)/(L þ R)/2) j ). Only those embryos with mild
coloboma where the lens could be accurately measured were counted
in the analysis.
Supporting Information
Figure S1. Frequencies of Common Developmental Defects Elicited
in WT Strains by Decreasing Hsp90 Function at 30% or 50% Epiboly
17AAG treatment (3.3 lM) initiated at: 30% epiboly (violet) or 50%
epiboly (green).
Found at doi:10.1371/journal.pgen.0030043.sg001 (39 KB PPT).
Figure S2. Abnormal Phenotypes in Morpholino Injected Embryos
(A) Absence of looping of the heart tube in Hsp90 morpholino-
injected embryos.
(B) Severe oedema in Hsp90 morpholino-injected embryos.
Found at doi:10.1371/journal.pgen.0030043.sg002 (27 MB TIF).
Video S1. In Some Severe Cases Drug-Induced Oedema Leads to
Abnormal Heart Morphology
Found at doi:10.1371/journal.pgen.0030043.sv001 (1.2 MB MOV).
Video S2. Normal Heart Looping
At around 22–30 hpf, the heart tube is gradually bent to form an s-
shaped loop that positions the ventricle to the right of the atrium;
this is in turn the ﬁrst morphological indication of the left-right
asymmetry in the zebraﬁsh embryo.
Found at doi:10.1371/journal.pgen.0030043.sv002 (591 KB MOV).
Video S3. Initiating 17AAG Treatment at 30% Epiboly Leads to High
Frequency of Heterotaxia
Heart chambers develop normally but the direction of the loop is
inverted, positioning the ventricle to the left of the atrium. Most of
these ﬁsh were viable and fertile (unpublished data).
Found at doi:10.1371/journal.pgen.0030043.sv003 (3.2 MB MOV).
Video S4. Radicicol-Induced Heterotaxia
Found at doi:10.1371/journal.pgen.0030043.sv004 (621 KB MOV).
Video S5. Absence of Looping of the Heart Tube in Radicicol-
Treated Embryos (I)
Found at doi:10.1371/journal.pgen.0030043.sv005 (1.2 MB MOV).
Video S6. Absence of Looping of the Heart Tube in Radicicol-
Treated Embryos (II)
Found at doi:10.1371/journal.pgen.0030043.sv006 (1.7 KB MOV).
Accession Numbers
The RefSeq (National Center for Biotechnology Information [NCBI])
(http://www.ncbi.nlm.nih.gov/RefSeq) accession numbers for the genes
discussed in this paper are for human: Hsp90AA1 (NM_001017963,
NP_001017963.1/.2); Hsp90AB1 (NM_007355.2, NP_031381.2);
Hsp90B1 (NM_198210, NP_937853); TRAP1 (NM_016292.1,
NP_057376.1); and for zebraﬁsh: hsp90a (NM_131328.1,
NP_571403.1); hsp90ab1 (NM_131310.1, NP_571385.1); pax6b
(NM_13164.1, NP_571716.1); sufu (XM_689570.1, XP_694662.1);
gli2 (gli2a) (NM_130967.1, NP_571042.1); and shh (shha)
(NM_131063.1, NP_571138.1).
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